Published in Trends Pharmacol Sci on April 01, 2002
The learning styles and the preferred teaching-learning strategies of first year medical students. J Clin Diagn Res (2013) 1.26
The effects of problem-based learning integration in a course on rational drug use: a comparative study between two Croatian medical schools. Eur J Clin Pharmacol (2008) 0.90
Favorable effect on postgraduate clinical practice of a drug-interaction exercise for undergraduate students. Eur J Clin Pharmacol (2006) 0.78
Exploring the context of drug use: a problem-based learning course in pharmacoepidemiology for undergraduate science students. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.78
Problem-based learning: panacea or cult? Trends Pharmacol Sci (2002) 0.77
Problem-based learning: a new pathway to competence? Trends Pharmacol Sci (2002) 0.75
Cooperative learning with role play in Chinese pharmacology education. Indian J Pharmacol (2012) 0.75
Problem-based learning: the Maastricht experience. Trends Pharmacol Sci (2002) 0.75
Problem-based learning: properly balanced learning? Trends Pharmacol Sci (2002) 0.75
The semi-structured triple jump--a new assessment tool reflects qualifications of tutors in a PBL course on basic pharmacology. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.75
Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta (2006) 1.91
The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA. J Biol Chem (2005) 1.49
Activation of type I phosphatidylinositol 4-phosphate 5-kinase isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42. J Biol Chem (2003) 1.42
Sphingosylphosphorylcholine-biological functions and mechanisms of action. Biochim Biophys Acta (2002) 1.23
Photolysis of intracellular caged sphingosine-1-phosphate causes Ca2+ mobilization independently of G-protein-coupled receptors. FEBS Lett (2003) 1.21
Regulation and cellular roles of phosphoinositide 5-kinases. Eur J Pharmacol (2004) 1.19
Epac and the cardiovascular system. Curr Opin Pharmacol (2007) 1.15
Epac- and Ca2+ -controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors. J Biol Chem (2004) 1.15
Direct stimulation of receptor-controlled phospholipase D1 by phospho-cofilin. EMBO J (2007) 1.14
Stimulation of phospholipase C-epsilon by the M3 muscarinic acetylcholine receptor mediated by cyclic AMP and the GTPase Rap2B. J Biol Chem (2002) 1.12
Novel teaching techniques in pharmacology. Naunyn Schmiedebergs Arch Pharmacol (2002) 1.12
Cyclic AMP-dependent and Epac-mediated activation of R-Ras by G protein-coupled receptors leads to phospholipase D stimulation. J Biol Chem (2006) 1.12
Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gbeta subunits. Specific activation of Gsalpha by an NDPK B.Gbetagamma complex in H10 cells. J Biol Chem (2002) 1.08
Problem- vs. lecture-based pharmacology teaching in a German medical school. Naunyn Schmiedebergs Arch Pharmacol (2002) 1.07
Dynamic phospholipid signaling by G protein-coupled receptors. Biochim Biophys Acta (2006) 1.06
p63RhoGEF and GEFT are Rho-specific guanine nucleotide exchange factors encoded by the same gene. Naunyn Schmiedebergs Arch Pharmacol (2004) 1.03
Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Gastroenterology (2006) 1.00
A mammalian Rho-specific guanine-nucleotide exchange factor (p164-RhoGEF) without a pleckstrin homology domain. Biochem J (2002) 0.94
Rap2B-dependent stimulation of phospholipase C-epsilon by epidermal growth factor receptor mediated by c-Src phosphorylation of RasGRP3. Mol Cell Biol (2004) 0.89
Lysophospholipid receptor-mediated calcium signaling in human keratinocytes. J Invest Dermatol (2008) 0.89
Regulator of G-protein signalling 3 redirects prototypical Gi-coupled receptors from Rac1 to RhoA activation. Cell Signal (2007) 0.88
Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins. Cell Signal (2003) 0.88
Inhibition of phospholipase C-epsilon by Gi-coupled receptors. Cell Signal (2004) 0.85
B cell receptor-induced growth arrest and apoptosis in WEHI-231 immature B lymphoma cells involve cyclic AMP and Epac proteins. Cell Signal (2009) 0.85
Arrestin-independent internalization of G protein-coupled receptors. Mol Pharmacol (2004) 0.85
Galpha(q)-mediated plasma membrane translocation of sphingosine kinase-1 and cross-activation of S1P receptors. Biochim Biophys Acta (2009) 0.85
Inhibition of Ca(2+) signalling by the sphingosine 1-phosphate receptor S1P(1). Cell Signal (2003) 0.84
Adhesiveness of human uterine epithelial RL95-2 cells to trophoblast: rho protein regulation. Mol Hum Reprod (2002) 0.83
Enhanced Ca2+ storage in sphingosine-1-phosphate lyase-deficient fibroblasts. Cell Signal (2010) 0.83
8-pCPT-conjugated cyclic AMP analogs exert thromboxane receptor antagonistic properties. Thromb Haemost (2010) 0.82
Antihypertensive action of 2-hydroxyoleic acid in SHRs via modulation of the protein kinase A pathway and Rho kinase. J Lipid Res (2006) 0.82
Distinct signaling pathways mediate cardiomyocyte phospholipase D stimulation by endothelin-1 and thrombin. J Mol Cell Cardiol (2002) 0.81
Transient relaxation of rat mesenteric microvessels by ceramides. Br J Pharmacol (2002) 0.81
Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.79
Spontaneous release of GDP from Gi proteins and inhibition of adenylyl cyclase in cardiac sarcolemmal membranes. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.78
Sphingosylphosphorylcholine, a naturally occurring lipid mediator, inhibits human platelet function. Br J Pharmacol (2003) 0.76
More hints on Wnts: gene profiling by beta2-adrenergic receptor-frizzled chimeras. Mol Pharmacol (2004) 0.75
Using antidepressants during pregnancy. CMAJ (2005) 0.75
Inhibition of Rho-kinase abrogates migration of human transitional cell carcinoma cells: results of an in vitro study. Urol Int (2010) 0.75